Regentis Biomaterials Develops and Patents New Solvent-Free Manufacturing Process That Increases GelrinC Production Yield by 400%

Breakthrough manufacturing process comes in preparation for upcoming commercial launch in Europe planned for later this ...
MyChesCo on MSN

NEXGEL to pay $15 million for Celularity regenerative biomaterial portfolio

LANGHORNE, PA — NEXGEL Inc. (Nasdaq: NXGL) said it will pay $15 million upfront to license and acquire a portfolio of ...

Regentis Biomaterials Ltd: Regentis Biomaterials Develops and Patents New Solvent-Free Manufacturing Process That Increases GelrinC Production Yield by 400%

Breakthrough manufacturing process comes in preparation for upcoming commercial launch in Europe planned for later this yearProprietary process is already patented in several countries and is pending ...
Nanowerk

New hydrogel platform mimics human tissue, can be controlled by light

Light-controlled hydrogel mimics real tissue mechanics, warming cells behave naturally, advancing drug testing and disease ...